Synopsis
In 2014, CDER’s Office of Pharmaceutical Quality (OPQ) created the Emerging Technology Program (ETP) to enable early engagement between FDA and drug companies seeking to use an advanced manufacturing technology. CDER is establishing a program to promote quality management maturity (QMM) at drug manufacturing establishments.
Automatically extracted from the original page. This is a short summary, not the full story, and may omit important detail.
Read the full story at FDA: drugs ↗
